US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Skycorp Solar Group Limited

2.25

+0.04101.86%

Post-market: 2.250.00000.00%16:04 EDT

Volume:319.26K

Turnover:702.07K

Market Cap:60.75M

PE:119.43

High:2.32

Open:2.17

Low:2.11

Close:2.21

Loading ...

Overview Company News Filings

Skycorp Solar Group Limited Announces Pricing of Its Initial Public Offering

THOMSON REUTERS

Skycorp Solar Group Limited Announces Pricing of Its Initial Public Offering

Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting

Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?

Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN

MT Newswires Live

Malaysia's ECRL: Residents in opposition-controlled states laud railway’s benefits, but could it create political tension?

Power Nickel Hole PN-24-095a Delivers 10.60% CuEq1 over 5.35 Metres Within 3.61% CuEq1 over 19.40 Metres

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PN\",,,,,undefined,":{"symbol":"PN","market":"US","secType":"STK","nameCN":"Skycorp Solar Group Limited","latestPrice":2.25,"timestamp":1752696000000,"preClose":2.209,"halted":0,"volume":319256,"hourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.25,"latestTime":"16:04 EDT","volume":1,"amount":2.25,"timestamp":1752696246002},"delay":0,"floatShares":10349999,"shares":27000000,"eps":0.018839,"marketStatus":"Not Yet Opened","change":0.041,"latestTime":"07-16 16:00:00 EDT","open":2.17,"high":2.315,"low":2.11,"amount":702067.7068,"amplitude":0.092802,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.018839,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752739200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1741064400000,"exchange":"NASDAQ","adjPreClose":2.209,"preHourTrading":{"tag":"盘前","latestPrice":2.2,"preClose":2.24,"latestTime":"09:29 EDT","volume":10105,"amount":21221.000197499998,"timestamp":1752672590009},"postHourTrading":{"tag":"盘后","latestPrice":2.25,"preClose":2.25,"latestTime":"16:04 EDT","volume":1,"amount":2.25,"timestamp":1752696246002},"volumeRatio":2.894113},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PN\",,,,,undefined,":{"symbol":"PN","floatShares":10349999,"roa":"2.28%","roe":"6.51%","lyrEps":0.018839,"volumeRatio":2.894113,"shares":27000000,"dividePrice":0,"high":2.315,"amplitude":0.092802,"preClose":2.209,"low":2.11,"week52Low":2.11,"pbRate":"3.70","psRate":"1.22","week52High":4.45,"institutionHeld":0,"latestPrice":2.25,"eps":0.018839,"divideRate":0,"volume":319256,"delay":0,"ttmEps":0.018839,"open":2.17,"prevYearClose":4,"prevWeekClose":2.41,"prevMonthClose":2.767,"prevQuarterClose":2.767,"fiveDayClose":2.4,"twentyDayClose":2.865,"sixtyDayClose":2.55},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517054196","title":"Skycorp Solar Group Limited Announces Pricing of Its Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2517054196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517054196?lang=en_us&edition=fundamental","pubTime":"2025-03-05 00:00","pubTimestamp":1741104000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA5JSCR0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PN"],"gpt_icon":0},{"id":"2517057426","title":"Skycorp Solar Group Limited Announces Pricing of Its Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2517057426","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517057426?lang=en_us&edition=fundamental","pubTime":"2025-03-05 00:00","pubTimestamp":1741104000,"startTime":"0","endTime":"0","summary":"Ningbo, China, March  04, 2025  (GLOBE NEWSWIRE) -- Skycorp Solar Group Limited (the “Company”), a solar PV product provider engaged in the manufacture and sale of solar cables and solar connectors, t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036745/0/en/Skycorp-Solar-Group-Limited-Announces-Pricing-of-Its-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PN","CN"],"gpt_icon":0},{"id":"2514320463","title":"Incyte to Unveil New Data from its Dermatology Portfolio at 2025 American Academy of Dermatology (AAD) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320463","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514320463?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:30","pubTimestamp":1740753000,"startTime":"0","endTime":"0","summary":"- Featured abstracts for ruxolitinib cream  include multiple presentations in atopic dermatitis and late-breaking data in prurigo nodularis . - Pipeline data presented includes data for axatilimab  in patients with dermatologic manifestations of chronic graft-versus-host disease . WILMINGTON, Del., February 28, 2025----Incyte  today announced that multiple abstracts featuring new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology  Annual Meeting, being held March 7–11, 2025, in Orlando.\"We look forward to sharing new data for ruxolitinib cream  across multiple indications, including prurigo nodularis, and axatilimab  in patients with dermatologic manifestations of chronic graft-versus-host disease  at this year's AAD Annual Meeting,\" said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation and Autoimmunity, Incyte. \"Incyte’s active participation in this key congress reinforces our commitment to addressing critical needs in dermatology","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incyte-unveil-data-dermatology-portfolio-143000768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PN","BK4107","BK4532","BK4550","BK4588","INCY","BK4117","AFG","BK4585"],"gpt_icon":0},{"id":"2514712330","title":"Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514712330","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514712330?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:01","pubTimestamp":1740690060,"startTime":"0","endTime":"0","summary":"Enrollment ongoing in Phase 3 barzolvolimab CSU studies; Phase 3 program in CIndU under developmentPhase 2 barzolvolimab EOE study fully accrued; Phase 2 study initiated in atopic dermatitis; enrollme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3034268/24180/en/Celldex-Reports-Fourth-Quarter-and-Year-End-2024-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SD","BK4139","CLDX","BK4213","PN","TSLP"],"gpt_icon":0},{"id":"2514180598","title":"Kymera Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180598","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514180598?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"KT-621  Phase 1 healthy volunteer trial ongoing, complete SAD/MAD data expected in June 2025. KT-621 Phase 1b trial in atopic dermatitis  patients expected to initiate in 2Q25 with data in 4Q25, followed by two parallel Phase 2b trials in AD and asthma starting in 4Q25 and 1Q26, respectively. KT-295  Phase 1 trial is expected to start in 2Q25, with data expected in 4Q25. KT-474/SAR444656  Phase 2b trials in hidradenitis suppurativa  and AD ongoing, led by partner Sanofi, with primary completion of both trials expected by mid-2026. New oral degrader program against a high-value immunology target to be announcedin early May 2025 in a company webcast. STAT6 Degrader ProgramKT-621 is an investigational, first-in-class, once daily, oral degrader of STAT6, the specific transcription factor responsible for IL-4/IL-13 signaling and the central driver of Th2 inflammation. In preclinical studies, KT-621 demonstrated dupilumab-like activity in several in vitro and in vivo models and was safe and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kymera-therapeutics-announces-fourth-quarter-120000004.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LENZ","KYMR","PN","IBD"],"gpt_icon":0},{"id":"2512483377","title":"What Makes Wave Life Sciences Ltd. (WVE) an Investment Bet?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483377","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512483377?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:43","pubTimestamp":1739976189,"startTime":"0","endTime":"0","summary":"Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The Fund performed roughly in line with the Benchmark, during a challenging quarter for the larger health care industry. A copy of the letter can be downloaded here. The fund declined 9.58%  in the quarter compared to a 9.75% decline for the Russell 3000 Health Care Index  and a 2.63% gain for the Russell 3000 Index . For the full year 2024, the fund appreciated 1.55% compared to 3.48% and 23.81% gains for the indexes. In addition, please check the fund’s top five holdings to know its best picks in 2024.Baron Health Care Fund stated the following regarding Wave Life Sciences Ltd.  in its Q4 2024 investor letter:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/makes-wave-life-sciences-ltd-144309816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["WVE","USAW.SI","QLD","NVIW.SI","TQQQ",".IXIC","PSQ","NQmain","SQQQ","PN","TSYW.SI","USJW.SI","MNQmain","BK4007","QID"],"gpt_icon":1},{"id":"2511406300","title":"Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN","url":"https://stock-news.laohu8.com/highlight/detail?id=2511406300","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511406300?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:29","pubTimestamp":1739381378,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics  said Wednesday it has entered a standby equity purchase agreement with YA II PN, or Yorkville.Under the deal, the company can sell up to $20 million worth of its common stock to Yorkville over the next 36 months but is not obligated to do so. The company also issued 305,960 common shares to Yorkville as a commitment for Yorkville to purchase these shares, according to a filing.Indaptus said it cannot sell more than about 2.8 million shares without shareholder approval or unless the average price per share is at least $0.82. Additionally, Yorkville can't own more than 9.99% of the company's voting shares.Before any shares can be sold, the company is required to file a registration statement with the US Securities and Exchange Commission for the shares involved in this agreement.The agreement replaces the previous purchase agreement the company had with Lincoln Park Capital Fund, which was terminated on Wednesday, it said.Shares of Indaptus Therapeutics fell past 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4215","PN","EQR","INDP","BK4588","BK4585","BK4139","LENZ"],"gpt_icon":0},{"id":"2510201410","title":"Malaysia's ECRL: Residents in opposition-controlled states laud railway’s benefits, but could it create political tension?","url":"https://stock-news.laohu8.com/highlight/detail?id=2510201410","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510201410?lang=en_us&edition=fundamental","pubTime":"2025-02-10 06:00","pubTimestamp":1739138400,"startTime":"0","endTime":"0","summary":"In the third of a four-part series on the East Coast Rail Link (ECRL), residents and experts speak with CNA on the project’s ground impact and how this might affect political support on both sides of the aisle.","market":"sg","thumbnail":"https://dam.mediacorp.sg/image/upload/s--6129WwQQ--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2025/01/20/Kota%20Bharu2.jpg?itok=ZWjyVkZG","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--6129WwQQ--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2025/01/20/Kota%20Bharu2.jpg?itok=ZWjyVkZG"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/asia/malaysia-ecrl-politics-pn-pas-flooding-4878581","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["LU0417517546.SGD","LU0208291251.USD","LU0320765489.SGD","BK4161","LU1989772923.USD","BK4580","LU0256863902.USD","5GC.SI","BK4588","LU0256863811.USD","PH","BK4585","LU0211331839.USD","PN","LU1989772840.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2509743235","title":"Power Nickel Hole PN-24-095a Delivers 10.60% CuEq1 over 5.35 Metres Within 3.61% CuEq1 over 19.40 Metres","url":"https://stock-news.laohu8.com/highlight/detail?id=2509743235","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509743235?lang=en_us&edition=fundamental","pubTime":"2025-02-05 16:00","pubTimestamp":1738742400,"startTime":"0","endTime":"0","summary":"TORONTO, Feb. 5, 2025 /PRNewswire/ - Power Nickel Inc.  is pleased to announce the return of the 5 holes of the fall campaign. These holes were testing multiple targets in the Lion zone area.Hole PN-24-095a tested the interpreted plunge of the Lion zone below previous drill holes. Power Nickel previously released photos of mineralized core from hole PN-24-095a , and assays have now confirmed that extension of the high-grade zone .The Lion Zone continues to provide excellent intersections and grades, conforming to interpreted geological modeling, and extending the mineralized area of the high-grade copper, gold, silver, and platinum group metals within the Lion zone. Visual logging of the first hole of the 2025 campaign, hole PN-25-96  suggests the high-grade trend will extend to depth and along strike from hole PN-24-95a reported in this news release.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/power-nickel-hole-pn-24-080000205.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/power-nickel-hole-pn-24-080000205.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4168","PN","PW","USD","PNPNF","BK4084","BK4234"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PN","date":"2025-07-15","current":145.03585,"percent":0.263736,"low":134.717094,"twenty":143.435296,"median":158.708202,"eighty":206.631945,"high":257.968904,"avg":169.156753,"sd":30.220938,"marketCap":68310000},"quantilePoints":[{"date":"2025-03-07","current":218.413672,"twenty":221.509299,"median":227.299267,"eighty":241.802853,"marketCap":102870000},{"date":"2025-03-14","current":216.120615,"twenty":215.432698,"median":218.413672,"eighty":226.554024,"marketCap":101790000},{"date":"2025-03-21","current":214.974086,"twenty":214.74478,"median":217.840407,"eighty":223.401071,"marketCap":101250000},{"date":"2025-03-28","current":174.84559,"twenty":214.171516,"median":218.413672,"eighty":223.802356,"marketCap":82350000},{"date":"2025-04-04","current":196.629631,"twenty":205.707843,"median":216.693879,"eighty":223.802356,"marketCap":92610000},{"date":"2025-04-11","current":174.84559,"twenty":185.164346,"median":214.974086,"eighty":223.401071,"marketCap":82350000},{"date":"2025-04-17","current":144.462586,"twenty":175.992118,"median":213.827558,"eighty":222.942459,"marketCap":68040000},{"date":"2025-04-25","current":146.182379,"twenty":169.571559,"median":205.245792,"eighty":221.738604,"marketCap":68850000},{"date":"2025-05-02","current":139.876472,"twenty":146.182379,"median":196.629631,"eighty":219.789506,"marketCap":65880000},{"date":"2025-05-09","current":142.169529,"twenty":144.462586,"median":179.718336,"eighty":218.413672,"marketCap":66960000},{"date":"2025-05-16","current":143.241533,"twenty":143.318351,"median":174.84559,"eighty":217.95506,"marketCap":67464900},{"date":"2025-05-23","current":161.087249,"twenty":143.318351,"median":174.05162,"eighty":216.808532,"marketCap":75870000},{"date":"2025-05-30","current":166.246627,"twenty":143.435296,"median":166.533259,"eighty":216.020867,"marketCap":78300000},{"date":"2025-06-06","current":170.832741,"twenty":144.003975,"median":164.526834,"eighty":215.492317,"marketCap":80460000},{"date":"2025-06-13","current":161.087249,"twenty":144.462586,"median":163.380306,"eighty":214.859433,"marketCap":75870000},{"date":"2025-06-20","current":158.794192,"twenty":144.462586,"median":162.520409,"eighty":214.400822,"marketCap":74790000},{"date":"2025-06-27","current":148.475436,"twenty":144.462586,"median":162.233777,"eighty":213.827558,"marketCap":69930000},{"date":"2025-07-03","current":134.717094,"twenty":144.462586,"median":161.087249,"eighty":212.451724,"marketCap":63450000},{"date":"2025-07-11","current":144.462586,"twenty":143.775816,"median":159.914923,"eighty":208.466391,"marketCap":68040000},{"date":"2025-07-15","current":145.03585,"twenty":143.435296,"median":158.708202,"eighty":206.631945,"marketCap":68310000}],"updateTime":1752728331370}}}